Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (331-340 of 488) with videos related to

Pageof 49
Sort By:
Journal of Clinical Immunology|October 29, 2022
CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling ResponsesVioleta Block, Eirini Sevdali, Mike Recher, et al.
Nature Cell Biology|March 14, 2026
An SP110-SP100 axis is a critical regulator of promyelocytic leukaemia body dynamics and mitotic fidelityEric J Aird, Julius Rabl, Tabea Knuesel, et al.
Journal of Autoimmunity|November 11, 2015
Two separate mechanisms of enforced viral replication balance innate and adaptive immune activationNamir Shaabani, Vishal Khairnar, Vikas Duhan, et al.
Rheumatology (Oxford, England)|January 9, 2017
Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritisAnne Kistner, Marc B Bigler, Kathrin Glatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2022
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and AzacitidineDaniel A Pollyea, Keith W Pratz, Andrew H Wei, et al.
American Journal of Hematology|June 27, 2015
Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalitiesAnne Wanquet, Thomas Prebet, Céline Berthon, et al.
Cancer|September 17, 2014
Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AMLJorge E Cortes, Stuart L Goldberg, Eric J Feldman, et al.
Nature Cell Biology|May 5, 2016
Self-organization of the human embryo in the absence of maternal tissuesMarta N Shahbazi, Agnieszka Jedrusik, Sanna Vuoristo, et al.
Science Translational Medicine|July 24, 2024
Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo modelsClement Larrue, Sarah Mouche, Paolo Angelino, et al.
The Journal of Clinical Investigation|September 7, 2006
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signalingKarl S Lang, Panco Georgiev, Mike Recher, et al.
Pageof 49

Showing results (331-340 of 488) with videos related to

Sort By:
Pageof 49
Journal of Clinical Immunology|October 29, 2022
CVID-Associated B Cell Activating Factor Receptor Variants Change Receptor Oligomerization, Ligand Binding, and Signaling ResponsesVioleta Block, Eirini Sevdali, Mike Recher, et al.
Nature Cell Biology|March 14, 2026
An SP110-SP100 axis is a critical regulator of promyelocytic leukaemia body dynamics and mitotic fidelityEric J Aird, Julius Rabl, Tabea Knuesel, et al.
Journal of Autoimmunity|November 11, 2015
Two separate mechanisms of enforced viral replication balance innate and adaptive immune activationNamir Shaabani, Vishal Khairnar, Vikas Duhan, et al.
Rheumatology (Oxford, England)|January 9, 2017
Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritisAnne Kistner, Marc B Bigler, Kathrin Glatz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2022
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and AzacitidineDaniel A Pollyea, Keith W Pratz, Andrew H Wei, et al.
American Journal of Hematology|June 27, 2015
Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalitiesAnne Wanquet, Thomas Prebet, Céline Berthon, et al.
Cancer|September 17, 2014
Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AMLJorge E Cortes, Stuart L Goldberg, Eric J Feldman, et al.
Nature Cell Biology|May 5, 2016
Self-organization of the human embryo in the absence of maternal tissuesMarta N Shahbazi, Agnieszka Jedrusik, Sanna Vuoristo, et al.
Science Translational Medicine|July 24, 2024
Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo modelsClement Larrue, Sarah Mouche, Paolo Angelino, et al.
The Journal of Clinical Investigation|September 7, 2006
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signalingKarl S Lang, Panco Georgiev, Mike Recher, et al.
Pageof 49